基因组复杂性的预后意义在患有CLL的患者中
Ellinor Goergen1, Othman Al-Sawaf1
1Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.
Leukemia & lymphoma
|April 9, 2024
概括
由复杂型 (CKT) 表示的基因组复杂性,影响慢性淋巴细胞白血病 (CLL) 治疗反应和存活率. 向治疗可以克服其负面预后影响,帮助患者分层.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
背景情况:
- 染色体异常驱动癌症的进展和治疗耐药性.
- 慢性淋巴细胞白血病 (CLL) 的基因组复杂性 (GC) 或复杂型 (CKT) 与化疗免疫治疗的不良结果有关.
- 向疗法显示有潜力克服GC在CLL的不良预后影响.
研究的目的:
- 审查基因组复杂性在CLL中的作用.
- 总结和评估在CLL诊断中测量GC的工具.
- 讨论CKT定义及其对临床结果和患者分层的影响.
主要方法:
- 关于CLL基因组复杂性的现有数据的文献综述.
- 测量基因组复杂性的诊断工具的摘要和评估.
- 对CKT与CLL患者的临床结果相关的研究分析.
主要成果:
- 基因组复杂性是CLL预后的一个重要因素.
- 测量GC的既定工具在常规诊断中具有不同的优缺点.
- CKT的定义影响了对GC对患者结果的影响的解释.
结论:
- 基因组复杂性对于了解CLL进展和治疗反应至关重要.
- 需要对CCT进行标准化定义和可靠的诊断工具.
- 了解GC和CCT对于有效的患者分层和个性化的CLL治疗策略至关重要.
更多相关视频
10:18From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
13.7K
13:21Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
10.0K
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
